Document Detail


Hypermethylation of CpG islands is more prevalent than hypomethylation across the entire genome in breast carcinogenesis.
MedLine Citation:
PMID:  22212995     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This study aimed to establish a high-throughput, genome-wide and non-gene-specific approach to assess the methylation status of multiple CpG islands in parallel and employ it to detect the CpG island methylation profiling alterations in breast carcinogenesis. We used methylation-sensitive restriction fingerprint (MSRF) to screen the permutations of primers that could detect varied and specific methylation profiling in genomic DNA isolated from four different cell lines. Five permutations of nine arbitrary primers were determined for the following experiments based on the above test. We then examined the methylation profiling alterations of CpG islands in 31 breast cancer tissue samples relative to their adjacent non-neoplastic tissues with modified MSRF that replaced silver staining with denatured high-performance liquid chromatography for size fraction. We found that two pairs of primers could reveal specific alterations of CpG methylation in the examined tissues, and 83.9% (26/31) of breast cancer tissues exhibited specific CpG island methylation profiling relative to their adjacent non-neoplastic tissues. Size fraction analysis revealed that hypermethylation of CpG islands was responsible for the aberrant methylation profiling in breast cancer tissues. Our work not only established a relative high-throughput, genome-wide and economic method to detect methylation alterations of CpG island profiling, but also revealed that hypermethylation of CpG islands was more prevalent than hypomethylation across the entire genome in our examined cancer tissues. The methylation profiling alterations revealed by two primer pairs used in the present study might be a novel marker for breast cancer.
Authors:
Jianxin Tan; Yumei Gu; Xiaomei Zhang; Sihong You; Xiaowei Lu; Senqing Chen; Xiao Han; Yujie Sun
Related Documents :
12377865 - Role of (99m)tc-hexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lu...
1611785 - Clinical experience with tc-99m mibi imaging in patients with malignant tumors. prelimi...
15085295 - Advantages and limitations of fdg pet in the follow-up of breast cancer.
15791435 - Pharmacokinetics and biodistribution of 177lu-labeled multivalent single-chain fv const...
2386915 - Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy aft...
19137425 - Low safb levels are associated with worse outcome in breast cancer patients.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-4
Journal Detail:
Title:  Clinical and experimental medicine     Volume:  -     ISSN:  1591-9528     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100973405     Medline TA:  Clin Exp Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Drastic difference in the photo-driven hydrogenation reactions of ruthenium complexes containing NAD...
Next Document:  Simultaneous determination of deoxycytidine diphosphate and deoxycytidine triphosphate by capillary ...